239 related articles for article (PubMed ID: 20852746)
1. Liver X Receptors as Therapeutic Targets for Managing Cholesterol: Implications for Atherosclerosis and Other Inflammatory Conditions.
Zhang Y; Chan JF; Cummins CL
Clin Lipidol; 2009 Feb; 4(1):29-40. PubMed ID: 20852746
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptors, atherosclerosis and inflammation.
Michael DR; Ashlin TG; Buckley ML; Ramji DP
Curr Atheroscler Rep; 2012 Jun; 14(3):284-93. PubMed ID: 22419222
[TBL] [Abstract][Full Text] [Related]
3. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
Nomiyama T; Bruemmer D
Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
5. Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis.
Rasheed A; Cummins CL
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087224
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.
Chinetti G; Fruchart JC; Staels B
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1128-31. PubMed ID: 17073767
[TBL] [Abstract][Full Text] [Related]
7. Liver x receptor: a novel therapeutic target.
Patel MB; Oza NA; Anand IS; Deshpande SS; Patel CN
Indian J Pharm Sci; 2008; 70(2):135-44. PubMed ID: 20046702
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptors as integrators of metabolic and inflammatory signaling.
Zelcer N; Tontonoz P
J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis.
Millatt LJ; Bocher V; Fruchart JC; Staels B
Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677
[TBL] [Abstract][Full Text] [Related]
10. Liver X receptors as potential therapeutic targets in atherosclerosis.
Zhu Y; Li Y
Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptor: a cardinal target for atherosclerosis and beyond.
Parikh M; Patel K; Soni S; Gandhi T
J Atheroscler Thromb; 2014; 21(6):519-31. PubMed ID: 24695022
[TBL] [Abstract][Full Text] [Related]
12. Identification of macrophage liver X receptors as inhibitors of atherosclerosis.
Tangirala RK; Bischoff ED; Joseph SB; Wagner BL; Walczak R; Laffitte BA; Daige CL; Thomas D; Heyman RA; Mangelsdorf DJ; Wang X; Lusis AJ; Tontonoz P; Schulman IG
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11896-901. PubMed ID: 12193651
[TBL] [Abstract][Full Text] [Related]
13. Squalene promotes cholesterol homeostasis in macrophage and hepatocyte cells via activation of liver X receptor (LXR) α and β.
Hien HTM; Ha NC; Thom LT; Hong DD
Biotechnol Lett; 2017 Aug; 39(8):1101-1107. PubMed ID: 28492976
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.
A-González N; Castrillo A
Biochim Biophys Acta; 2011 Aug; 1812(8):982-94. PubMed ID: 21193033
[TBL] [Abstract][Full Text] [Related]
15. Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells.
Endo-Umeda K; Makishima M
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614590
[TBL] [Abstract][Full Text] [Related]
16. Regulation of macrophage function in inflammation and atherosclerosis.
Shibata N; Glass CK
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S277-81. PubMed ID: 18987388
[TBL] [Abstract][Full Text] [Related]
17. Liver x receptors: potential novel targets in cardiovascular diseases.
Bruemmer D; Law RE
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):533-40. PubMed ID: 16503873
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.
Majdalawieh A; Ro HS
Nucl Recept Signal; 2010 Apr; 8():e004. PubMed ID: 20419060
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
20. Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.
Ricote M; Valledor AF; Glass CK
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):230-9. PubMed ID: 14592855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
